Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study-Reference-Cited by-同舟云学术

Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study

Published:2005-06 Issue:3 Volume:68 Page:258-264
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Pozzilli P.,Manfrini S.,Buzzetti R.,Lampeter E.,Leeuw I.De.,Iafusco D.,Prisco M.,Ionescu-Tirgoviste C.,Kolouskovà S.,Linn T.,Ludvigsson J.,Madàcsy L.,Mrozikiewicz A.Seremak.,Mrozikiewicz P.M.,Podar T.,Vavrinec J.,Vialettes B.,Visalli N.,Yilmaz T.,Browne P.D.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference32 articles.

1. The pathogenesis of insulin-dependent diabetes mellitus;Atkinson;New Engl. J. Med.,1994

2. Analysis of 20 years of prospective registration of childhood onset diabetes time trends and birth cohort effects. Swedish Childhood Diabetes Study Group;Dahlquist;Acta paediatrica,2000

3. Incidence of childhood type 1 diabetes world-wide. Diabetes mondiale (DiaMond) project group;Karvonen;Diab. Care,2000

4. Metabolic and immune parameters at clinical onset of insulin-dependent diabetes: a population-based study;Pozzilli;Metabolism,1998

5. Binder, homogeneity in pattern of decline of (-cell function in IDDM;Snorgaard;Diab. Care,1992

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between partial remission phase in type 1 diabetes and vitamin D receptor Fok1 rs2228570 polymorphism;Journal of Pediatric Endocrinology and Metabolism;2024-09-03

2. Dopamine Agonists as a Novel “Cure” for Autoimmune Diabetes;JCEM Case Reports;2024-01-08

3. What Is a Honeymoon in Type 1, Can It Go into Remission?;Endocrinology and Metabolism Clinics of North America;2023-03

4. Oral Pharmacological Treatment of Neonatal Diabetes;Neonatal and Early Onset Diabetes Mellitus;2023

5. Glutamic acid decarboxylase immunotherapy for type 1 diabetes;Current Opinion in Endocrinology, Diabetes & Obesity;2022-07-02